Related Experiment Video
Updated: Nov 18, 2025

Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic
Published on: November 7, 2020
[Course of Revision of the Diagnosis and Treatment Protocol for COVID-19 and the Forensic Contribution]
1Beijing Source of Judicial Identification Center of Scientific Evidence, Beijing 100062, China.
Insights
Chinese health authorities rapidly updated COVID-19 treatment guidelines, incorporating forensic insights. Autopsies on over ten cases enhanced understanding of disease characteristics and improved clinical management strategies for coronavirus disease 2019.
Area of Science:
- Public Health
- Infectious Diseases
- Forensic Pathology
Background:
- The National Health Commission of China issued multiple versions of COVID-19 diagnosis and treatment guidelines between January and March 2020.
- Initial guidelines focused on clinical aspects, with evolving understanding of the novel coronavirus pneumonia.
- Forensic medicine experts advocated for pathological examination to deepen understanding of the disease.
Purpose of the Study:
- To detail the iterative optimization of COVID-19 diagnosis and treatment guidelines.
- To highlight the contribution of forensic pathology to understanding COVID-19's clinical and pathological features.
- To demonstrate how integrated insights improved scientific clinical management of COVID-19 cases.
Main Methods:
- Systematic review and analysis of seven successive editions of China's COVID-19 diagnosis and treatment guidelines.
- Incorporation of recommendations from forensic medicine experts during guideline revisions.
- Performance of pathological examinations on post-mortem remains from over ten COVID-19 cases.
Main Results:
- Guidelines evolved from 'Novel Coronavirus Pneumonia' to 'COVID-19', refining etiology, clinical presentation, diagnostics, and therapeutics.
- Pathological examinations provided crucial data on the clinical and pathological characteristics of COVID-19.
- Forensic input and autopsy findings directly contributed to enhancing the scientific basis of clinical management protocols.
Conclusions:
- The rapid, iterative revision of clinical guidelines, informed by forensic pathology, significantly advanced the scientific management of COVID-19.
- Pathological studies were vital for understanding the disease's full spectrum and improving treatment strategies.
- Interdisciplinary collaboration, including forensic medicine, is crucial for effectively managing novel infectious diseases.
Abstract:
From January 15 to March 3, 2020, seven editions of the guidelines for the diagnosis and treatment of COVID-19 have been issued successively by the National Health Commission of the People's Republic of China, and the guidelines' name was changed from Guidelines for Diagnosis and Treatment of Novel Coronavirus Pneumonia to Diagnosis and Treatment for COVID-19. It optimized and perfected the etiology, clinical manifestations and types, diagnostic procedures and specific treatment measures of the disease, so that the clinical management of the cases was more scientific. In the revision process of guidelines for diagnosis and treatment, forensic medicine experts have also made some positive suggestions on clinical diagnosis and treatment. Especially regarding the pathological changes of COVID-19, they have repeatedly called for rapid autopsy at different levels. With the support, understanding and cooperation of all parties, pathological examination of more than ten cases of the remains were carried out, which made an important contribution to the understanding of the clinical characteristics and pathological characteristics of the disease and the improvement of treatment plans.
Related Concept Videos
Standards of Care II
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Standards of Care I
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Acute Coronary Syndrome III: Diagnostic Studies

